{
  "resourceType": "MedicationStatement",
  "id": "e10aG32TY3GxQKga7ejscpB-l24kUZEAL4.pKXNJLOlA3",
  "extension": [
    {
      "valueBoolean": true,
      "url": "http://nictiz.nl/fhir/StructureDefinition/zib-MedicationUse-AsAgreedIndicator"
    },
    {
      "valueReference": {
        "reference": "https://haikuor-staging.providence.org/fhirproxy/api/FHIR/STU3/Practitioner/el6zA5XIe17CrANWXBRRiFg3",
        "display": "Kiley E Ziegler, MD"
      },
      "url": "http://nictiz.nl/fhir/StructureDefinition/zib-MedicationUse-Prescriber"
    }
  ],
  "identifier": [
    {
      "use": "usual",
      "system": "urn:oid:1.2.840.114350.1.13.297.3.7.2.798268",
      "value": "1659164"
    }
  ],
  "basedOn": [
    {
      "reference": "https://haikuor-staging.providence.org/fhirproxy/api/FHIR/STU3/MedicationRequest/e-FVJbzfqLchp3x1sXG8xB-Vc.9ssLOcXow07wXiYvFs3",
      "identifier": {
        "use": "usual",
        "system": "urn:oid:1.2.840.114350.1.13.297.3.7.2.798268",
        "value": "1659164"
      },
      "display": "adalimumab (HUMIRA PEN-CD/UC/HS STARTER) 40 mg/0.8 mL injection (pen)"
    }
  ],
  "status": "unknown",
  "category": {
    "coding": [
      {
        "system": "http://hl7.org/fhir/medication-statement-category",
        "code": "community",
        "display": "Community"
      }
    ],
    "text": "Community"
  },
  "medicationReference": {
    "reference": "https://haikuor-staging.providence.org/fhirproxy/api/FHIR/STU3/Medication/eHcSzoz4II8XirdWYeft4d-sRLMTp-sogONJn3wRl631TSmFrq3lD6HiI.fi5OHi23",
    "display": "HUMIRA PEN-CD/UC/HS STARTER 40 MG/0.8ML SUBQ PNKT"
  },
  "effectivePeriod": {
    "start": "2022-09-13"
  },
  "dateAsserted": "2022-09-13",
  "informationSource": {
    "reference": "https://haikuor-staging.providence.org/fhirproxy/api/FHIR/STU3/Practitioner/el6zA5XIe17CrANWXBRRiFg3",
    "display": "Kiley E Ziegler, MD"
  },
  "subject": {
    "reference": "https://haikuor-staging.providence.org/fhirproxy/api/FHIR/STU3/Patient/eQ6bfRoF2gnLFGdZ3Gu-cyg3",
    "display": "Beacon, Cindy \"CeCe\""
  },
  "note": [
    {
      "text": "test"
    }
  ],
  "dosage": [
    {
      "text": "Inject 160 mg (contents of 4 pens) sub-q as initial dose, then, 2 weeks after initial dose, inject 80 mg (contents of 2 pens) sub-q..",
      "additionalInstruction": [
        {
          "text": "Inject 160 mg (contents of 4 pens) sub-q as initial dose, then, 2 weeks after initial dose, inject 80 mg (contents of 2 pens) sub-q."
        }
      ],
      "patientInstruction": "Inject 160 mg (contents of 4 pens) sub-q as initial dose, then, 2 weeks after initial dose, inject 80 mg (contents of 2 pens) sub-q..",
      "timing": {
        "repeat": {
          "boundsPeriod": {
            "start": "2022-09-13"
          }
        }
      }
    }
  ]
}
